Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting 36 homolog (VPS36) is a core component of the endosomal sorting complex required for transport II (ESCRT-II), which is conserved from yeast to mammals[1][2][4]. VPS36 contains a GLUE domain, enabling it to bind ubiquitin and endosomal phospholipids and couples recognition of ubiquitinated cargos with their sequestration into multivesicular bodies (MVBs) for lysosomal degradation[1][2][4]. ESCRT-II, as a complex, forms a critical nexus for endocytic trafficking, facilitating the downregulation and degradation of plasma membrane proteins[2][4]. In plants and mammals, functional VPS36 is essential for normal development, vacuolar biogenesis, and degradation of plasma membrane proteins[3]. In disease contexts, VPS36 has been implicated in cancer (e.g., reduced VPS36 expression is associated with advanced prostate cancer and poor prognosis) and plays a role in antiviral host defense by suppressing viral replication[1]. Currently, there are no drugs that specifically target VPS36, and it is not considered a direct therapeutic target; its importance lies mainly in fundamental cellular protein trafficking and disease pathophysiology[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting 36 homolog (VPS36).